Wellington Management Group
PMVP icon

Wellington Management Group’s PMV Pharmaceuticals PMVP Stock Holding History

Wellington Management Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-542,883
Closed -$3.33M – 1903
2023
Q3 		$3.33M Sell
542,883
-23,060
-4% -$159K ﹤0.01% 1379
2023
Q2 		$3.54M Sell
565,943
-304,111
-35% -$1.59M ﹤0.01% 1353
2023
Q1 		$4.15M Buy
870,054
+45,484
+6% +$320K ﹤0.01% 1332
2022
Q4 		$7.17M Sell
824,570
-268,546
-25% -$2.86M ﹤0.01% 1177
2022
Q3 		$13M Sell
1,093,116
-35,451
-3% -$512K ﹤0.01% 1029
2022
Q2 		$16.1M Buy
1,128,567
+1,064,111
+1,651% +$15.5M ﹤0.01% 1002
2022
Q1 		$1.34M Buy
64,456
+33,119
+106% +$584K ﹤0.01% 1684
2021
Q4 		$724K Buy
+31,337
New +$757K ﹤0.01% 1863
2021
Q3 		– Sell
-970,364
Closed -$33.1M – 2244
2021
Q2 		$33.1M Sell
970,364
-37,359
-4% -$1.25M 0.01% 958
2021
Q1 		$33.1M Sell
1,007,723
-297,456
-23% -$11.7M 0.01% 930
2020
Q4 		$79.2M Sell
1,305,179
-340,643
-21% -$13.4M 0.01% 651
2020
Q3 		$57.1M Buy
+1,645,822
New +$60.6M 0.01% 667

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Wellington Management Group's PMVP Position: Q4 2023 in Review

Wellington Management Group sold out of PMV Pharmaceuticals (PMVP) in Q4 2023, closing a stake of 542,883 shares — an estimated $3.33M sold.

Wellington Management Group first reported a position in PMVP in Q3 2020 and held it in 12 quarters. The position peaked at $79.2M in Q4 2020. 98 funds tracked by Wall St. Rank hold PMVP as of Q4 2023.

  • Wellington Management Group reported no remaining PMV Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Wellington Management Group sold 542,883 PMV Pharmaceuticals shares in Q4 2023, an estimated $3.33M.
  • Wellington Management Group first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 12 quarters.
  • Wellington Management Group's PMV Pharmaceuticals position peaked at $79.2M in Q4 2020.
  • 98 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2023.

Based on Wellington Management Group's 13F filing for Q4 2023, filed 12 Feb 2024.